Dr. @TonyMok9 at #ASCO26 presents update on CROWN in ALK+ NSCLC. After 7y, median PFS with lorlatinib still not reached. Between years 5 and 7, only 4 progression events occurred. Unusual but fantastic to see such a tail with targeted therapy - this is truly raising the bar.
@giampygiampygi Ma per favore, Bastoni ha fatto una cretinata ma gli juventini, proprio loro, non devono parlare perché sono storicamente medaglia d’oro della specialità
Dr. Tina Cascone with the Keynote Presentation of Day 1 at the IX Conferenza Oncologia Polmonare. Neoadjuvant and perioperative immunotherapy has made a massive impact on resectable NSCLC with more to come. A major paradigm shift - now need new combinations and biomarkers.
La nostra avventura ad #AIOM si è conclusa con il progetto #ATLAS:
✅ Piattaforma #atlante BiomarkerAtlas;
✅ È un progetto scientifico;
✅ Dal 2024 è una #fondazione
🙏🏼Grazie ai fondatori e a tutti i ricercatori con #ATLAS danno luce e speranza al futuro della ricerca ✨
9,000 oncologists attending the ESMO plenary… and they’re all vibing with joy to be there.
(Okay, maybe it’s an AI-generated video — but the enthusiasm is real!)
#ESMO2025#Oncology#AIhumor#PlenaryVibes
✨ Welcome to #WCLC25! ✨
From your Co-Chairs 🇮🇪🇨🇭🇮🇹🇪🇸may this week spark bold ideas, meaningful connections, and new horizons in lung cancer care
Here’s to a week of science & collaboration, in every session
@IASLC@NReguart@IsaOpitz@UmbertoMalapel1@DrJNaidoo#LCSM